Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy

American Journal of Roentgenology

Volumn 200, Issue 2, 2013, Pages 355-362

  Gallotti, Anna ^a,b   Perez Johnston, Rocio ^b   Bonaffini, Pietro A ^b,c   Ingkakul, Thun ^b   Deshpande, Vikram ^b   Fernandez Del Castillo, Carlos ^b   Sahani, Dushyant V ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Incidental lesions; MDCT; Neuroendocrine tumors; Pancreas; Pancreatic malignancy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORPHOLOGY; CANCER RECURRENCE; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LYMPH NODE HYPERPLASIA; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PANCREAS CALCIFICATION; PANCREAS RESECTION; PANCREATIC NEUROENDOCRINE TUMOR; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; CALCINOSIS; CONTRAST MEDIA; FEMALE; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873585748     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.8037     Document Type: Article

References (46)

1. Horton KM, Hruban RH, Yeo C, Fishman EK. Multi-detector row CT of pancreatic islet cell tumors. RadioGraphics 2006; 26:453-464
2. Oberg K. Pancreatic endocrine tumors. Semin Oncol 2010; 37:594-618
3. Rha SE, Jung SE, Lee KH, Ku YM, Byun JY, Lee JM. CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 2007; 62:371-377
4. Dixon E, Pasieka JL. Functioning and nonfunctioning neuroendocrine tumors of the pancreas. Curr Opin Oncol 2007; 19:30-35
5. Fitzgerald TL, Hickner ZJ, Schmitz M, Seah A, Kort EJ. Increasing incidence of nonfunctional neuroendocrine tumors of the pancreas. (abstract) In: 2007 Gastrointestinal cancers symposium. Alexandria, VA: ASCO, 2007: abstract no. 124
6. Fitzgerald TL, Hickner ZJ, Schmitz M, Kort EJ. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas 2008; 37:134-138
7. Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience. Gastrointest Endosc 2010; 71:1185-1193
8. Kazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 2006; 141:765-769; discussion, 769-770
9. Simon P, Spilcke-Liss E, Wallaschofski H. Endocrine tumors of the pancreas. Endocrinol Metab Clin North Am 2006; 35:431-447, xii
10. O'Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol 2008; 34:324-332
11. Stephen AE, Hodin RA. Neuroendocrine tumors of the pancreas, excluding gastrinoma. Surg Oncol Clin N Am 2006; 15:497-510
12. Vagefi PA, Razo O, Deshpande V, et al. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg 2007; 142:347-354
13. Tan EH, Tan CH. Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2011; 2:28-43
14. Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA. Neuroendocrine neoplasms of the gastrointestinal tract. Dtsch Arztebl Int 2011; 108:305-312
15. Jarufe NP, Coldham C, Orug T, et al. Neuroendocrine tumours of the pancreas: predictors of survival after surgical treatment. Dig Surg 2005; 22:157-162
16. Rockall AG, Reznek RH. Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab 2007; 21:43-68
17. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008; 95:627-635
18. Bahra M, Jacob D, Pascher A, et al. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas. J Gastroenterol Hepatol 2007; 22:930-935
19. Falconi M, Bettini R, Boninsegna L, Crippa S, Butturini G, Pederzoli P. Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 2006; 7:150-156
20. Solcia E, Klöppel G, Sobin LH. World Health Organization international histological classification of tumours: histological typing of endocrine tumours, 2nd ed. Berlin, Germany: Springer-Verlag, 2000
21. Rindi G, Klöppel G, Alhman H, et al.; all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449:395-401
22. Rindi G. The ENETS guidelines: the new TNM classification system. Tumori 2010; 96:806-809
23. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010; 39:707-712
24. Siddiqui AA, Brown LJ, Hong SK, et al. Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasound-guided fine needle aspiration. Dig Dis Sci 2011; 56:3370-3375
25. Figueiredo FA, Giovannini M, Monges G, et al. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc 2009; 70:907-914
26. Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004; 60:378-384
27. Fitzgerald TL, Smith AJ, Ryan M, et al. Surgical treatment of incidentally identified pancreatic masses. Can J Surg 2003; 46:413-418
28. Sachs T, Pratt WB, Callery MP, Vollmer CM Jr. The incidental asymptomatic pancreatic lesion: nuisance or threat? J Gastrointest Surg 2009; 13:405-415
29. D'Onofrio M, Gallotti A, Pozzi Mucelli R. Imaging techniques in pancreatic tumors. Expert Rev Med Devices 2010; 7:257-273
30. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR 1997; 168:1439-1443
31. Klöppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007; 21:15-31
32. Kalra MK, Maher MM, Mueller PR, Saini S. State-of-the-art imaging of pancreatic neoplasms. Br J Radiol 2003; 76:857-865
33. Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am 2007; 21:409-432
34. Buetow PC, Parrino TV, Buck JL, et al. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR 1995; 165:1175-1179
35. Soga J, Yakuwa Y. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999; 18:13-22
36. Dumortier J, Ratineau C, Roche C, Lombard-Bohas C, Chayvialle JA, Scoazec JY. Angiogenesis and endocrine tumors (in French). Bull Cancer 1999; 86:148-153
37. Ichikawa T, Peterson MS, Federle MP, et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 2000; 216:163-171
38. Green DE, Woodward PJ. The management of indeterminate incidental findings detected at abdominal CT. Semin Ultrasound CT MR 2005; 26:2-13
39. Hayat M. Cancer imaging: instrumentation and applications, vol. 2. Burlington, MA: Elsevier Academic Press, 2007
40. Goh BK, Ooi LL, Tan YM, et al. Clinico-pathological features of cystic pancreatic endocrine neoplasms and a comparison with their solid counterparts. Eur J Surg Oncol 2006; 32:553-556
41. Han JH, Kim MH, Moon SH, et al. Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors (in Korean). Korean J Gastroenterol 2009; 53:98-105
42. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3:401-410
43. Marion-Audibert AM, Barel C, Gouysse G, et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003; 125:1094-1104
44. Takahashi Y, Akishima-Fukasawa Y, Kobayashi N, et al. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin Cancer Res 2007; 13:187-196
45. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009; 250:407-416
46. Rodallec M, Vilgrain V, Couvelard A, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 2006; 6:77-85